Vitrolife acquires Igenomix and creates a global leader in reproductive health
Vitrolife AB (publ) (“Vitrolife”) has entered into a definitive agreement to acquire 100% of the shares in Igenomix S.L.[1] (“Igenomix”) from EQT and other shareholders (together the “Sellers”). The combination will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services.Igenomix – a global leader in reproductive genetic testing services Igenomix is a global leader in women’s health and reproductive genetic testing services for IVF clinics